VANECK ETF TR (BBH) - 5i Research

VANECK ETF TR (BBH $181.47)
- $181.47 P/E (TTM): 20.86X Cap: $358M
- View BBH Profile
- View Questions on BBH

{tplLang.businessdescription | toLang tLang}

{ profileData.description }

{tplLang.details | toLang tLang}

{tplLang.ceo | toLang tLang}

{profileData.profile.details.ceo}

{tplLang.employees | toLang tLang}

{profileData.profile.details.employees | numeraljs '0,0'}

{tplLang.issuetype | toLang tLang}

{profileData.profile.details.issuetype | asIssueType}

{tplLang.industryclassifications | toLang tLang}

{tplLang.sector | toLang tLang}

{profileData.profile.classification.sector}

{tplLang.industry | toLang tLang}

{profileData.profile.classification.industry}

{tplLang.toolname| toLang tLang}

There is no {tplLang.toolname| toLang tLang} currently available for {data.symbolstring}.

iShares Biotechnology ETF (IBB $161.65)
- $161.65 P/E (TTM): 20.63X Cap: $7.79B
- View IBB Profile
- View Questions on IBB
Moderna Inc. (MRNA $51.38)
- $51.38 Cap: $20.37B
- View MRNA Profile
- View Questions on MRNA
VANECK ETF TR (BBH $181.47)
- $181.47 P/E (TTM): 20.86X Cap: $358M
- View BBH Profile
- View Questions on BBH

Q: Currently not invested in this sector. Considering starting a position in this company. Appreciate your insights.
Thank you

Read Answer Asked by Larry on September 07, 2023

iShares Biotechnology ETF (IBB $161.65)
- $161.65 P/E (TTM): 20.63X Cap: $7.79B
- View IBB Profile
- View Questions on IBB
CRISPR Therapeutics AG (CRSP $46.24)
- $46.24 Cap: $4.43B
- View CRSP Profile
- View Questions on CRSP
VANECK ETF TR (BBH $181.47)
- $181.47 P/E (TTM): 20.86X Cap: $358M
- View BBH Profile
- View Questions on BBH

Q: I am down by 55% on this company, although it is a small position (.8%) & I consider it speculative. Your comments will help me decide to wait, sell, or buy more. Thanks

Read Answer Asked by Louisa on March 30, 2023

Regeneron Pharmaceuticals Inc. (REGN $732.87)
- $732.87 P/E (TTM): 17.78X Cap: $77.47B
- View REGN Profile
- View Questions on REGN
Johnson & Johnson (JNJ $235.37)
- $235.37 P/E (TTM): 21.54X Cap: $566.91B
- View JNJ Profile
- View Questions on JNJ
Eli Lilly and Company (LLY $906.70)
- $906.70 P/E (TTM): 39.98X Cap: $856.66B
- View LLY Profile
- View Questions on LLY
Merck & Company Inc. (MRK $114.18)
- $114.18 P/E (TTM): 15.69X Cap: $282.29B
- View MRK Profile
- View Questions on MRK
Pfizer Inc. (PFE $26.97)
- $26.97 P/E (TTM): 20.15X Cap: $153.41B
- View PFE Profile
- View Questions on PFE
Thermo Fisher Scientific Inc (TMO $474.39)
- $474.39 P/E (TTM): 26.51X Cap: $176.22B
- View TMO Profile
- View Questions on TMO
Novo Nordisk A/S (NVO $36.53)
- $36.53 P/E (TTM): 10.42X Cap: $363.68B
- View NVO Profile
- View Questions on NVO
iShares Biotechnology ETF (IBB $161.65)
- $161.65 P/E (TTM): 20.63X Cap: $7.79B
- View IBB Profile
- View Questions on IBB
Moderna Inc. (MRNA $51.38)
- $51.38 Cap: $20.37B
- View MRNA Profile
- View Questions on MRNA
VANECK ETF TR (BBH $181.47)
- $181.47 P/E (TTM): 20.86X Cap: $358M
- View BBH Profile
- View Questions on BBH
iShares U.S. Pharmaceuticals ETF (IHE $83.98)
- $83.98 P/E (TTM): 21.49X Cap: $965M
- View IHE Profile
- View Questions on IHE

Q: I'm looking for names in the large cap pharma and biotech sectors. Can you suggest two stocks for each sector that look attractive to you right now for a 5+ year horizon? Thanks.

Read Answer Asked by Stefan on March 10, 2023